Download Unicorn Signals App

Powered By EquityPandit
Latest News

Zydus Cadila gets patent litigation settled

Zydus Cadila has said that the patent litigation relating to Allergan’s Delzicol, that is used in treating uclerative colitis, has been settled.

Zydus Cadila has said in a statement that the patent litigation relating to Allergan’s Delzicol (mesalamine) has been settled.

It added that “As a result of the settlement, and if approved by FDA, its US subsidiary, Zydus Pharmaceuticals (USA) Inc, will be able to market its generic version of Delzicol in the US beginning on March 1, 2020, or earlier under certain circumstances.”

Read EquityPandit’s Nifty Pharma Outlook for this week

Get Daily Prediction & Stocks Tips On Your Mobile